{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:52:21Z","timestamp":1790250741328,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1208\/s12248-019-0323-0","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T18:15:11Z","timestamp":1556561711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography"],"prefix":"10.1208","volume":"21","author":[{"given":"Irene","family":"Hern\u00e1ndez Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Blaickner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Wulkersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-5781","authenticated-orcid":false,"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"1","key":"323_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2133\/dmpk.24.37","volume":"24","author":"H Kusuhara","year":"2009","unstructured":"Kusuhara H, Sugiyama Y. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metab Pharmacokinet. 2009;24(1):37\u201352.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"3","key":"323_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"K Giacomini","year":"2010","unstructured":"Giacomini K, Huang S, Tweedie D. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215\u201336.","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 7","key":"323_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcph.722","volume":"56","author":"O Langer","year":"2016","unstructured":"Langer O. Use of PET imaging to evaluate transporter-mediated drug-drug interactions. J Clin Pharmacol. 2016;56(Suppl 7):143\u201356.","journal-title":"J Clin Pharmacol"},{"key":"323_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/cpt.437","volume":"100","author":"G Patilea-Vrana","year":"2016","unstructured":"Patilea-Vrana G, Unadkat JD. Transport vs. metabolism: what determines the pharmacokinetics and pharmacodynamics of drugs? Insights from the extended clearance model. Clin Pharmacol Ther. 2016;100:413\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"323_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/clpt.2013.78","volume":"94","author":"X Chu","year":"2013","unstructured":"Chu X, Korzekwa K, Elsby R, Fenner K, Galetin A, Lai Y, et al. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clin Pharmacol Ther. 2013;94:126\u201341.","journal-title":"Clin Pharmacol Ther"},{"key":"323_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","volume":"189","author":"N Tournier","year":"2018","unstructured":"Tournier N, Stieger B, Langer O. Imaging techniques to study drug transporter function in vivo. Pharmacol Ther. 2018;189:104\u201322.","journal-title":"Pharmacol Ther"},{"key":"323_CR7","doi-asserted-by":"crossref","unstructured":"Pastor CM, Langer O, Van Beers BE. Liver imaging and hepatobiliary contrast media. Contrast Media Mol Imaging. 2018;2487405.","DOI":"10.1155\/2018\/2487405"},{"issue":"12","key":"323_CR8","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/01.wcb.0000045042.03034.42","volume":"22","author":"RN Gunn","year":"2002","unstructured":"Gunn RN, Gunn SR, Turkheimer FE, Aston JA, Cunningham VJ. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J Cereb Blood Flow Metab. 2002;22(12):1425\u201339.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"323_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"323_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ana.410150302","volume":"15","author":"MA Mintun","year":"1984","unstructured":"Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15(3):217\u201327.","journal-title":"Ann Neurol"},{"key":"323_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/B978-012744482-6.50026-0","volume-title":"Emission Tomography","author":"E MORRIS","year":"2004","unstructured":"Morris ED, Endres CJ, Schmidt KC, Christian BT, Muzic RF, Fisher RE. Kinetic modeling in positron emission tomography. In: Wernick MN, Aarsvold JN, editors. Emission tomography. 1st edn. Burlington: Elsevier; 2004. p. 499\u2013540."},{"key":"323_CR12","first-page":"76","volume":"5","author":"VJ Cunningham","year":"1995","unstructured":"Cunningham VJ, Lammertsma AA. Radioligand studies in brain: kinetic analysis of PET data. Med Chem Res. 1995;5:76\u201396.","journal-title":"Med Chem Res"},{"issue":"2","key":"323_CR13","first-page":"73","volume":"8","author":"S Keiding","year":"2018","unstructured":"Keiding S, S\u00f8rensen M, Frisch K, Gormsen LC, Munk OL. Quantitative PET of liver functions. Am J Nucl Med Mol Imaging. 2018;8(2):73\u201385.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"323_CR14","first-page":"2345","volume":"3","author":"Y Cui","year":"2005","unstructured":"Cui Y, Bai J. Comparison of parameter estimations using dual-input and arterial-input in liver kinetic studies of FDG metabolism. IEEE Eng Med Biol. 2005;3:2345\u20138.","journal-title":"IEEE Eng Med Biol"},{"issue":"24","key":"323_CR15","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1158\/1078-0432.CCR-09-0189","volume":"15","author":"PS Hammerman","year":"2009","unstructured":"Hammerman PS, Janne PA, Johnson BE. Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res. 2009;15(24):7502\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"323_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1078-0432.CCR-10-1934","volume":"17","author":"MA Elmeliegy","year":"2011","unstructured":"Elmeliegy MA, Carcaboso AM, Tagen M, Bai F, Stewart CF. Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation. Clin Cancer Res. 2011;17(1):89\u201399.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"323_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1124\/jpet.109.162321","volume":"333","author":"H Kodaira","year":"2010","unstructured":"Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y. Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J Pharmacol Exp Ther. 2010;333(3):788\u201396.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"323_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/cpt.888","volume":"104","author":"M Bauer","year":"2018","unstructured":"Bauer M, Matsuda A, Wulkersdorfer B, Philippe C, Traxl A, \u00d6zvegy-Laczka C, et al. Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography. Clin Pharmacol Ther. 2018;104(1):139\u201347.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"323_CR19","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1021\/acs.molpharmaceut.8b00588","volume":"15","author":"M Bauer","year":"2018","unstructured":"Bauer M, Traxl A, Matsuda A, Karch R, Philippe C, Nics L, et al. Effect of rifampicin on the distribution of [11C]erlotinib to the liver, a translational PET study in humans and in mice. Mol Pharm. 2018;15(10):4589\u201398.","journal-title":"Mol Pharm"},{"issue":"5","key":"323_CR20","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1118\/1.3702456","volume":"39","author":"ME Kamasak","year":"2012","unstructured":"Kamasak ME. Computation of variance in compartment model parameter estimates from dynamic PET data. Med Phys. 2012;39(5):2638\u201348.","journal-title":"Med Phys"},{"issue":"6","key":"323_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2967\/jnumed.115.171579","volume":"57","author":"M S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen M, Munk OL, \u00d8rntoft NW, Frisch K, Andersen KJ, Mortensen FV, et al. Hepatobiliary secretion kinetics of conjugated bile acids measured in pigs by [11C]cholylsarcosine PET. J Nucl Med. 2016;57(6):961\u20136.","journal-title":"J Nucl Med"},{"issue":"2","key":"323_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00259-010-1620-0","volume":"38","author":"M Winterdahl","year":"2011","unstructured":"Winterdahl M, Keiding S, S\u00f8rensen M, Mortensen FV, Alstrup AK, Munk OL. Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs. Eur J Nucl Med Mol I. 2011;38(2):263\u201370.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"7","key":"323_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"B Davies","year":"1993","unstructured":"Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10(7):1093\u20135.","journal-title":"Pharm Res"},{"issue":"2","key":"323_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jhep.2017.02.023","volume":"67","author":"NW \u00d8rntoft","year":"2017","unstructured":"\u00d8rntoft NW, Munk OL, Frisch K, Ott P, Keiding S, S\u00f8rensen M. Hepatobiliary transport kinetics of the conjugated bile acid tracer [11C]CSar quantified in healthy humans and patients by positron emission tomography. J Hepatol. 2017;67(2):321\u20137.","journal-title":"J Hepatol"},{"issue":"12","key":"323_CR25","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2967\/jnumed.115.161273","volume":"56","author":"A Traxl","year":"2015","unstructured":"Traxl A, Wanek T, Mairinger S, Stanek J, Filip T, Sauberer M, et al. Breast cancer resistance protein and p-glycoprotein influence in vivo disposition of [11C]erlotinib. J Nucl Med. 2015;56(12):1930\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"323_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13550-018-0434-0","volume":"8","author":"D Amor","year":"2018","unstructured":"Amor D, Goutal S, Marie S, Caill\u00e9 F, Bauer M, Langer O, et al. Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. EJNMMI Res. 2018;8(1):81.","journal-title":"EJNMMI Res"},{"issue":"3","key":"323_CR27","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1152\/ajpendo.2001.281.3.E524","volume":"281","author":"A Bertoldo","year":"2001","unstructured":"Bertoldo A, Peltoniemi P, Oikonen V, Knuut J, Nuutila P, Cobelli C. Kinetic modeling of [18F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab. 2001;281(3):E524\u201336.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"323_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/jlts.2002.31654","volume":"8","author":"JN Vauthey","year":"2002","unstructured":"Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8(3):233\u201340.","journal-title":"Liver Transpl"},{"issue":"2","key":"323_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01117450","volume":"6","author":"K Yamaoka","year":"1977","unstructured":"Yamaoka K, Nakagawa T, Uno T. Application of Akaike\u2019s Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1977;6(2):165\u201375.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"323_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00004728-198607000-00020","volume":"10","author":"BM Mazoyer","year":"1986","unstructured":"Mazoyer BM, Huesman RH, Budinger TF, Knittel BL. Dynamic PET data analysis. J Comput Assist Tomogr. 1986;10(4):645\u201353.","journal-title":"J Comput Assist Tomogr"},{"key":"323_CR31","first-page":"69","volume-title":"PET pharmacokinetic course manual 2010","author":"AA Lammertsma","year":"2010","unstructured":"Lammertsma AA. Receptor kinetics - modelling and practical approach. In: Dittrich S, van den Hoff J, Maguire RP, editors. PET pharmacokinetic course manual 2010. Scotland: Loch Lomond; 2010. p. 69\u201384."},{"issue":"1","key":"323_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1208\/s12248-009-9088-1","volume":"11","author":"HM Jones","year":"2009","unstructured":"Jones HM, Gardner IB, Watson KJ. Modelling and PBPK simulation in drug discovery. AAPS J. 2009;11(1):155\u201366.","journal-title":"AAPS J"},{"key":"323_CR33","unstructured":"Tortora GJ, Derrickson B. The digestive system. In: Guarascio M, Rama L, Myers L, editors. Principles of anatomy and physiology. 15th edn. Hoboken, NJ: John Wiley & Sons; 2014. p. 898\u2013952."},{"key":"323_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/dom.13244","volume":"20","author":"LC Gormsen","year":"2018","unstructured":"Gormsen LC, S\u00f8ndergaard E, Christensen NL, Jakobsen S, Nielsen EHT, Munk OL, et al. Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: a 3-month placebo controlled clinical trial in patients with type 2 diabetes and healthy controls. Diabetes Obes Metab. 2018;20:1435\u201344.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"323_CR35","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1007\/s00259-009-1140-y","volume":"36","author":"N Kudomi","year":"2009","unstructured":"Kudomi N, Jarvisalo MJ, Kiss J, Borra R, Viljanen A, Viljanen T, et al. Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions. Eur J Nucl Med Mol Imaging. 2009;36(12):2014\u201326.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"323_CR36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1088\/1361-6560\/aa553c","volume":"62","author":"MD Chouhan","year":"2017","unstructured":"Chouhan MD, Bainbridge A, Atkinson D, Punwani S, Mookerjee RP, Lythgoe MF, et al. Improved hepatic arterial fraction estimation using cardiac output correction of arterial input functions for liver DCE MRI. Phys Med Biol. 2017;62(4):1533\u201346.","journal-title":"Phys Med Biol"},{"issue":"10","key":"323_CR37","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/jcbfm.2011.107","volume":"31","author":"P Zanotti-Fregonara","year":"2011","unstructured":"Zanotti-Fregonara P, Chen K, Liow JS, Fujita M, Innis RB. Image-derived input function for brain PET studies: many challenges and few opportunities. J Cereb Blood Flow Metab. 2011;31(10):1986\u201398.","journal-title":"J Cereb Blood Flow Metab"},{"key":"323_CR38","first-page":"795","volume":"42","author":"OL Munk","year":"2001","unstructured":"Munk OL, Bass L, Roelsgaard K, Bender D, Hansen SB, Keiding S. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med. 2001;42:795\u2013801.","journal-title":"J Nucl Med"},{"issue":"5","key":"323_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1124\/dmd.118.080408","volume":"46","author":"K Kaneko","year":"2018","unstructured":"Kaneko K, Tanaka M, Ishii A, Katayama Y, Nakaoka T, Irie S, et al. A clinical quantitative evaluation of hepatobiliary transport of [11C]dehydropravastatin in humans using positron emission tomography. Drug Metab Dispos. 2018;46(5):719\u201328.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"323_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2967\/jnumed.111.098681","volume":"53","author":"T Takashima","year":"2012","unstructured":"Takashima T, Kitamura S, Wada Y, Tanaka M, Shigihara Y, Ishii H, et al. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me. J Nucl Med. 2012;53(5):741\u20138.","journal-title":"J Nucl Med"},{"issue":"4","key":"323_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1118\/1.598560","volume":"26","author":"J Kissel","year":"1999","unstructured":"Kissel J, Port RE, Zaers J, Bellemann ME, Strauss LG, Haberkorn U, et al. Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach. Med Phys. 1999;26(4):609\u201315.","journal-title":"Med Phys"},{"issue":"11","key":"323_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jcph.751","volume":"56","author":"J Li","year":"2016","unstructured":"Li J, Kim S, Shields AF, Douglas KA, McHugh CI, Lawhorn-Crews JM, et al. Integrating dynamic positron emission tomography and conventional pharmacokinetic studies to delineate plasma and tumor pharmacokinetics of FAU, a prodrug bioactivated by thymidylate synthase. J Clin Pharmacol. 2016;56(11):1433\u201347.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"323_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40262-016-0490-4","volume":"56","author":"P Gandia","year":"2017","unstructured":"Gandia P, Jaudet C, Everaert H, Heemskerk J, Vanbinst AM, de Mey J, et al. Population pharmacokinetic approach applied to positron emission tomography: computed tomography for tumor tissue identification in patients with glioma. Clin Pharmacokin. 2017;56(8):953\u201361.","journal-title":"Clin Pharmacokin"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-019-0323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-019-0323-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-019-0323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:06:03Z","timestamp":1588028763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-019-0323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1208\/s12248-019-0323-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both clinical studies were registered under EUDRACT number 2015-001593-18 and were approved by the Ethics Committee of the Medical University of Vienna. Written consent was obtained from the study participants before their inclusion into the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}],"article-number":"61"}}